The Effect of Weekly Semaglutide Treatment on Energy Expenditure

NARecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 1, 2024

Primary Completion Date

August 15, 2025

Study Completion Date

September 15, 2025

Conditions
Obesity; Drug
Interventions
DRUG

Semaglutide

Solution for subcutaneous (s.c. - under the skin) injection. 0.25 mg semaglutide once weekly for four weeks, 0.5 mg semaglutide once weekly for four weeks, 0.1 mg semaglutide once weekly for four weeks, 1.7 mg semaglutide once weekly for four weeks followed by 2.4 mg semaglutide once weekly for eight weeks

DRUG

Placebo

Solution for subcutaneous (s.c. - under the skin) injection

Trial Locations (1)

Unknown

RECRUITING

Shenzhen Institute of Advanced Technology, Shenzhen

All Listed Sponsors
lead

Shenzhen Institutes of Advanced Technology ,Chinese Academy of Sciences

OTHER